生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | GNE-9605 is a powerful, orally administered inhibitor specifically targeting Leucine-rich repeat kinase 2 (LRRK2) with an IC50 of 18.7 nM. It blocks LRRK2 Ser1292 autophosphorylation and is applicable in Parkinson's disease (PD)[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.22mL 0.44mL 0.22mL |
11.12mL 2.22mL 1.11mL |
22.23mL 4.45mL 2.22mL |
参考文献 |
---|